Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases.
Preterm (PT) infants are at increased risk of experiencing complications of vaccine-preventable diseases but are less likely to receive immunizations on time. Medically stable PT and low birth weight (LBW) infants should receive full doses of diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, hepatitis B, poliovirus, and pneumococcal conjugate vaccines at a chronologic age consistent with the schedule recommended for full-term infants. Infants with birth weight less than 2000 g may require modification of the timing of hepatitis B immunoprophylaxis depending on maternal hepatitis B surface antigen status. All PT and LBW infants benefit from receiving influenza vaccine beginning at 6 months of age before the beginning of and during the influenza season. All vaccines routinely recommended during infancy are safe for use in PT and LBW infants. The occurrence of mild vaccine-attributable adverse events are similar in both full-term and PT vaccine recipients. Although the immunogenicity of some childhood vaccines may be decreased in the smallest PT infants, antibody concentrations achieved usually are protective.
Saari
Thomas N
TN
D016667:Bacterial Capsules; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage; D005260:Female; D018073:Haemophilus Vaccines / Q000008:administration & dosage; D006509:Hepatitis B; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007115:Immunization Schedule; D007136:Immunoglobulins / Q000008:administration & dosage; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007252:Influenza Vaccines / Q000008:administration & dosage; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012449:Safety; D014611:Vaccination / Q000009:adverse effects; D014612:Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D018074:Vaccines, Conjugate / Q000008:administration & dosage
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D017325:Hepatitis B Vaccines; D007136:Immunoglobulins; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D011055:Poliovirus Vaccine, Oral; D011135:Polysaccharides, Bacterial; D014612:Vaccines; D018074:Vaccines, Conjugate; C045213:hepatitis B hyperimmune globulin